News
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu
Thermogenesis Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies
ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement
ThermoGenesis Announces 1-for-45 Reverse Stock Split
ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update
ThermoGenesis Closes $2.05 Million Public Offering
ThermoGenesis Prices $2.05 Million Public Offering
H.C. Wainwright 24th Annual Global Investment Conference (2022)
ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Thermogenesis Holdings to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2021, and Provides Corporate Update
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update